In theory I agree with you. But the "day to day" stock price concerns down at .08 cents have gone on now for basically 7 months, since the July Conferences. That's more than a few "days." A small biotech can't be all long term promise and have no short term cash engine. Something cash generating has got to give soon.....to keep the MANF train on track, let alone the upcoming Eltoprazine trial.